Arrakis Therapeutics, Inc.

Massachusetts
Registered In
02/22/2016
Incorp. Date
Foreign
Registration Type
Delaware
Foreign Jurisdiction

Company Summary

Arrakis Therapeutics, Inc. at 828 Winter St, Waltham, Ma 02451 lists Michael Gilman and Chris O'donnell as associates.

Registered In
Massachusetts
Incorporation Date
Registration Type
Foreign
Foreign Jurisdiction
Delaware
Company Type
Foreign Corporation
Status
Active
Find Social Profiles
Search Other Resources
SEC | EDGAR Trellis.Law Recent News
C T Corporation System Registered Agent
155 FEDERAL ST STE 700, BOSTON, MA 02110
Michael Gilman CEO
Chris O'donnell Director
Raj Parekh Director
Jakob Loven Director
Katrine Bosley Director
Colleen Cuffaro Director
Michael Gilman Director
Richard Gaster Director
Erik Spek Secretary
Login to view more!
You must login to view additional information on 3 more associates. Don't have an account? Sign Up, it's free!
828 WINTER ST, WALTHAM, MA 02451 View Map

Financial Information for Arrakis Therapeutics, Inc.

Form 5500

ARRAKIS THERAPEUTICS, INC

828 Winter Street, Waltham, Ma 02451 (781) 502-5401 EIN:47-5064524 Plan Admin:Gary Vogel
Year Plan Name Participants BOY/EOY Assets BOY/EOY
2023 Plan NameARRAKIS THERAPEUTICS 401K PLAN Plan #001 Participants BOY/EOY109 / 112 Assets BOY/EOY$4,018,928 / $6,549,819 2023 ARRAKIS THERAPEUTICS 401K PLAN - Plan #001 109 / 112 $4,018,928 / $6,549,819
2022 Plan NameARRAKIS THERAPEUTICS 401K PLAN Plan #001 Participants BOY/EOY89 / 109 Assets BOY/EOY$3,076,983 / $4,018,928 2022 ARRAKIS THERAPEUTICS 401K PLAN - Plan #001 89 / 109 $3,076,983 / $4,018,928
2021 Plan NameARRAKIS THERAPEUTICS 401K PLAN Plan #001 Participants BOY/EOY69 / 89 Assets BOY/EOY$2,145,239 / $3,076,983 2021 ARRAKIS THERAPEUTICS 401K PLAN - Plan #001 69 / 89 $2,145,239 / $3,076,983
2020 Plan NameARRAKIS THERAPEUTICS 401K PLAN Plan #001 Participants BOY/EOY43 / 69 Assets BOY/EOY$1,199,243 / $2,145,239 2020 ARRAKIS THERAPEUTICS 401K PLAN - Plan #001 43 / 69 $1,199,243 / $2,145,239
2019 Plan NameARRAKIS THERAPEUTICS 401K PLAN Plan #001 Participants BOY/EOY32 / 42 Assets BOY/EOY$631,591 / $1,199,243 2019 ARRAKIS THERAPEUTICS 401K PLAN - Plan #001 32 / 42 $631,591 / $1,199,243
Benefit & Retirement Plans based on Form 5500.
Related Business Names:
Arrakis Therapeutics Inc. Registered in New Jersey
View Report
Arrakis Therapeutics Inc Registered in Pennsylvania
Waltham, MA Harrisburg, PA View Report
Arrakis Therapeutics, Inc. Registered in North Carolina
Raleigh, NC Waltham, MA View Report
Address Match:828 Winter St Waltham, MA
Arrakis Therapeutics Securities Corporation Registered in Massachusetts
Waltham, MA View Report
Fresenius Medical Care Clovis, LLC Registered in California
Waltham, MA Attn Tax Waltham, MA (1 more) View Report
Waltham, MA (2 more) View Report
Fresenius Medical Care Oceanside, LLC Registered in California
Waltham, MA (2 more) View Report
Northway Biotech Inc. Registered in Massachusetts
Waltham, MA View Report
Waltham, MA Orlando, FL (1 more) View Report
Xilio Development, Inc. Registered in Massachusetts
Waltham, MA View Report
Xilio Securities Corp. Registered in Massachusetts
Waltham, MA View Report
Xilio Therapeutics, Inc. Registered in Massachusetts
Waltham, MA View Report
Xilio Concerto LLC Registered in Massachusetts
Waltham, MA Cambridge, MA View Report
Xilio Therapeutics LLC Registered in Massachusetts
Waltham, MA View Report
Akrevia Therapeutics LLC Registered in California
Waltham, MA (1 more) View Report
Northway Biotech, Inc. Registered in California
San Francisco, CA Waltham, MA (1 more) View Report

The following government agencies have contributed data:

Secretary of the Commonwealth of Massachusetts U.S. Department of Labor
Have questions?
You can easily find answers to common questions on the Frequently Asked Questions page.
IncTrace, LLC is not a consumer reporting agency as defined by the Fair Credit Reporting Act, 15 USC § 1681 et seq, (“FCRA”). We prohibit the use of this website or any information derived from it to make any determinations regarding employment, consumer credit, insurance, tenant screening, or any other purpose that would require FCRA compliance.
© 2025 IncTrace, LLC
Delaware, United States